Insulet Corp (PODD)

$311.69 +2.58 (0.83%)
Market Cap 21.76B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 73.63
Forward PE 67.37
Profit Margin 20.19%
Debt to Equity Ratio 0.96
Volume 538,500
Avg Vol 665,020
Day's Range N/A - N/A
Shares Out 70.39M
Stochastic %K 56%
Beta 1.40
Analysts Strong Sell
Price Target $363.27

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 10:25 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $309.11 Contracts: $PODD June 18, 2026 $310 Calls Scale in: $45.70- $55.85 Scale out: $71.08-$91.39 Can Easily Capture: 60% ROI Blended DTE: 258 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
StockAutoPro
StockAutoPro Oct. 4 at 10:22 PM
$PODD: Buy target $307.12 Sell target $324.57 Recent product approvals could drive significant growth for this leading diabetes management company.
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 4:48 AM
$PODD: Unusual Options Activity Alerted PUT flow observed 25x contracts at Strike price of $290 Exp on 01/16/2026 with Premium of $52K and showing BEARISH Sentiment
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 10:41 AM
Enter: $PODD NOV 21 2025 $320 CALLS Buy in Price: $15.10 - $18.50 Take Profit: $23.86 Stop Bleeding: $13.29 ROI Potential: 58% Exit Within: 177 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 3 at 1:24 AM
$PODD Share Price: $312.27 Contract Selected: Jan 16, 2026 $310 Calls Buy Zone: $25.16 – $31.08 Target Zone: $47.16 – $57.64 Potential Upside: 77% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
geniuscali
geniuscali Oct. 1 at 2:52 PM
$PODD ouch news?
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 4:17 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $311.71 Contracts: $PODD June 18, 2026 $320 Calls Scale in: $39.95- $48.82 Scale out: $62.14-$79.89 Can Easily Capture: 60% ROI Blended DTE: 262 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 30 at 8:44 AM
Enter: $PODD NOV 21 2025 $320 CALLS Buy in Price: $20.24 - $21.25 Take Profit: $36.84 Stop Bleeding: $17.81 ROI Potential: 82% Exit Within: 322 Minutes https://moneygroup.us/alerts
0 · Reply
RenaissanceTrading
RenaissanceTrading Sep. 30 at 7:18 AM
$PODD $290 target
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 29 at 1:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $318.00 Contracts: $PODD June 18, 2026 $320 Calls Scale in: $42.51- $51.96 Scale out: $66.13-$85.02 Can Easily Capture: 60% ROI Blended DTE: 263 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Latest News on PODD
These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

Sep 22, 2025, 10:19 AM EDT - 14 days ago

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

ADI BA CCL COIN DASH NUE NVDA

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Sep 18, 2025, 7:00 AM EDT - 18 days ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:25 AM EDT - 20 days ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Insulet Announces CFO Transition

Sep 16, 2025, 7:00 AM EDT - 20 days ago

Insulet Announces CFO Transition

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 2:31 PM EDT - 27 days ago

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 6:33 PM EDT - 4 weeks ago

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 6 weeks ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

Aug 19, 2025, 1:20 PM EDT - 6 weeks ago

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

CSCO RKT IGV

Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 6 weeks ago

Insulet to Participate in Upcoming Investor Conferences

20 stocks in the S&P 500 that are high achievers this earnings season

Aug 15, 2025, 8:52 AM EDT - 7 weeks ago

20 stocks in the S&P 500 that are high achievers this earnings season

ANET APH COIN CTRA EQT EXE FICO

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Aug 13, 2025, 11:49 PM EDT - 7 weeks ago

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Aug 7, 2025, 1:08 PM EDT - 2 months ago

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 2 months ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Aug 7, 2025, 8:39 AM EDT - 2 months ago

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Aug 7, 2025, 7:00 AM EDT - 2 months ago

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 2 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY SYK

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Jul 21, 2025, 10:27 AM EDT - 2 months ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF DXCM FSLR INTU LLY MA

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Jul 8, 2025, 6:00 AM EDT - 3 months ago

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Jun 19, 2025, 6:00 AM EDT - 3 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

20 stocks bucking bad trends on Wall Street — what might be next for them?

Jun 10, 2025, 10:53 AM EDT - 4 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO BSX TRMB BAC C

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Jun 10, 2025, 8:30 AM EDT - 4 months ago

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

20 stocks of companies that have improved profit margins and are expected to grow quickly

Jun 9, 2025, 9:28 AM EDT - 4 months ago

20 stocks of companies that have improved profit margins and are expected to grow quickly

AMD AVGO CSGP DASH ENPH FICO FTNT

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 23, 2025, 6:01 AM EDT - 4 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 5 months ago

Outlier Money Flows Lift Insulet

Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 5 months ago

Insulet Announces Publication of 2024 Sustainability Report

20 stocks of companies showing excellent earnings-season trends even as the economy cools

May 12, 2025, 11:18 AM EDT - 5 months ago

20 stocks of companies showing excellent earnings-season trends even as the economy cools

AMD APH CF CTRA DVN ENPH EQT

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

May 9, 2025, 6:31 PM EDT - 5 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

May 9, 2025, 12:31 PM EDT - 5 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MNST TSLA

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

May 9, 2025, 11:05 AM EDT - 5 months ago

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 5 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 5 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 5 months ago

Insulet beats quarterly profit estimates on insulin pump demand

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 8, 2025, 4:01 PM EDT - 5 months ago

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 5 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Insulet Appoints Ashley McEvoy President and CEO

Apr 28, 2025, 6:00 AM EDT - 5 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 6:00 AM EDT - 6 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Mar 19, 2025, 4:01 PM EDT - 7 months ago

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Insulet Announces Pricing of Senior Notes Due 2033

Mar 18, 2025, 4:32 PM EDT - 7 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Announces Proposed Financing Transactions

Mar 18, 2025, 7:35 AM EDT - 7 months ago

Insulet Announces Proposed Financing Transactions

Insulet Leans Bullish (Technical Analysis)

Mar 17, 2025, 11:53 PM EDT - 7 months ago

Insulet Leans Bullish (Technical Analysis)

Insulet to Host Investor Day on June 5, 2025

Mar 11, 2025, 6:00 AM EDT - 7 months ago

Insulet to Host Investor Day on June 5, 2025

Insulet Sales Keep Rising

Feb 26, 2025, 8:04 AM EST - 7 months ago

Insulet Sales Keep Rising

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Feb 21, 2025, 1:28 PM EST - 8 months ago

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 11:37 PM EST - 8 months ago

Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Feb 20, 2025, 4:01 PM EST - 8 months ago

Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Jan 13, 2025, 4:01 PM EST - 9 months ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 10, 2025, 6:00 AM EST - 9 months ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Heavy Interest in Insulet's Insulin Delivery Device

Dec 27, 2024, 3:47 PM EST - 10 months ago

Heavy Interest in Insulet's Insulin Delivery Device

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Dec 5, 2024, 11:05 AM EST - 10 months ago

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Dec 4, 2024, 4:28 PM EST - 10 months ago

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 10:25 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $309.11 Contracts: $PODD June 18, 2026 $310 Calls Scale in: $45.70- $55.85 Scale out: $71.08-$91.39 Can Easily Capture: 60% ROI Blended DTE: 258 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
StockAutoPro
StockAutoPro Oct. 4 at 10:22 PM
$PODD: Buy target $307.12 Sell target $324.57 Recent product approvals could drive significant growth for this leading diabetes management company.
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 4:48 AM
$PODD: Unusual Options Activity Alerted PUT flow observed 25x contracts at Strike price of $290 Exp on 01/16/2026 with Premium of $52K and showing BEARISH Sentiment
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 10:41 AM
Enter: $PODD NOV 21 2025 $320 CALLS Buy in Price: $15.10 - $18.50 Take Profit: $23.86 Stop Bleeding: $13.29 ROI Potential: 58% Exit Within: 177 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 3 at 1:24 AM
$PODD Share Price: $312.27 Contract Selected: Jan 16, 2026 $310 Calls Buy Zone: $25.16 – $31.08 Target Zone: $47.16 – $57.64 Potential Upside: 77% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
geniuscali
geniuscali Oct. 1 at 2:52 PM
$PODD ouch news?
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 4:17 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $311.71 Contracts: $PODD June 18, 2026 $320 Calls Scale in: $39.95- $48.82 Scale out: $62.14-$79.89 Can Easily Capture: 60% ROI Blended DTE: 262 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 30 at 8:44 AM
Enter: $PODD NOV 21 2025 $320 CALLS Buy in Price: $20.24 - $21.25 Take Profit: $36.84 Stop Bleeding: $17.81 ROI Potential: 82% Exit Within: 322 Minutes https://moneygroup.us/alerts
0 · Reply
RenaissanceTrading
RenaissanceTrading Sep. 30 at 7:18 AM
$PODD $290 target
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 29 at 1:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $318.00 Contracts: $PODD June 18, 2026 $320 Calls Scale in: $42.51- $51.96 Scale out: $66.13-$85.02 Can Easily Capture: 60% ROI Blended DTE: 263 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 28 at 10:58 PM
Enter: $PODD NOV 21 2025 $330 CALLS Buy in Price: $17.00 - $18.00 Take Profit: $33.83 Stop Bleeding: $14.96 ROI Potential: 99% Exit Within: 268 Minutes https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 27 at 10:44 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $323.98 Contracts: $PODD June 18, 2026 $330 Calls Scale in: $43.39- $53.03 Scale out: $67.49-$86.78 Can Easily Capture: 60% ROI Blended DTE: 265 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 10:28 PM
Enter: $PODD OCT 17 2025 $330 CALLS Buy in Price: $6.20 - $6.51 Take Profit: $9.05 Stop Bleeding: $5.46 ROI Potential: 46% Exit Within: 109 Minutes https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Sep. 26 at 3:13 PM
$PODD: Impressive 37.4% rally over the past year — can it continue? 🚀 Omnipod 5's unique features and international expansion drive strong adoption, but macro uncertainties and sole product reliance pose risks. ⚠️ The Zacks Consensus Estimate projects impressive EPS growth for 2025 and 2026. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2757476/insulet-stock-surges-374-in-12-months-whats-driving-the-rally?cid=sm-stocktwits-2-2757476-body-14330&ADID=SYND_STOCKTWITS_TWEET_2_2757476_BODY_14330
0 · Reply
ZacksResearch
ZacksResearch Sep. 26 at 12:03 PM
$PODD up 37.4% in 12 months — what’s fueling this rally? 🚀 The stock has delivered a massive run, and now the focus is on the key drivers behind this momentum. Full breakdown here 👉 https://www.zacks.com/stock/news/2757476/insulet-stock-surges-374-in-12-months-whats-driving-the-rally?cid=sm-stocktwits-2-2757476-teaser-14235&ADID=SYND_STOCKTWITS_TWEET_2_2757476_TEASER_14235
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 25 at 11:57 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PODD Current Share Price: $326.97 Contracts: $PODD June 18, 2026 $330 Calls Scale in: $42.15- $51.51 Scale out: $65.56-$84.29 Can Easily Capture: 60% ROI Blended DTE: 266 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 25 at 11:48 AM
Enter: $PODD OCT 17 2025 $330 CALLS Buy in Price: $6.70 - $8.50 Take Profit: $12.53 Stop Bleeding: $5.90 ROI Potential: 87% Exit Within: 70 Minutes https://moneygroup.us/alerts
0 · Reply
PatriciaRuby438
PatriciaRuby438 Sep. 23 at 10:48 AM
$PODD Medical device innovation. Insulin pump adoption. Testing key support level. Reimbursement environment stable.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 23 at 1:11 AM
Enter: $PODD OCT 17 2025 $340 CALLS Buy in Price: $7.30 - $10.80 Take Profit: $13.43 Stop Bleeding: $6.42 ROI Potential: 84% Exit Within: 347 Minutes https://moneygroup.us/alerts
0 · Reply
tomwade
tomwade Sep. 22 at 2:18 PM
$SENS Big concerns but not for SENS https://stocktwits.com/news-articles/markets/equity/dexcom-stock-slumps-after-hunterbrook-media-investigation-raises-concerns-about-its-g7-device/chD3f5NR3Tm $SENS $DXCM $ABBV $TNDM $PODD
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 22 at 10:01 AM
Enter: $PODD OCT 17 2025 $340 CALLS Buy in Price: $7.30 - $7.60 Take Profit: $13.58 Stop Bleeding: $6.42 ROI Potential: 86% Exit Within: 309 Minutes https://moneygroup.us/alerts
0 · Reply
JInvestTrade
JInvestTrade Sep. 21 at 11:20 PM
https://stocktwits.com/news-articles/markets/equity/dexcom-stock-slumps-after-hunterbrook-media-investigation-raises-concerns-about-its-g7-device/chD3f5NR3Tm $SENS $DXCM $ABBV $TNDM $PODD
1 · Reply